{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:13:41Z","timestamp":1788182021210,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","award":["972229"],"award-info":[{"award-number":["972229"]}],"id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["224117\/Z\/21\/Z"],"award-info":[{"award-number":["224117\/Z\/21\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ymthe.2026.02.036","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:50:14Z","timestamp":1771919414000},"page":"3518-3534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["An adenoviral-vectored vaccine protects mice against aerosol challenge with Yersinia pestis"],"prefix":"10.1016","volume":"34","author":[{"given":"Christina","family":"Dold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Silva-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2847-9407","authenticated-orcid":false,"given":"Young Chan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Blackwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Linder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Bridges-Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mwila","family":"Kasanyinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Lopez-Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Challis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Hatch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Fotheringham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Beernink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian V.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon G.P.","family":"Funnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S.","family":"Rollier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.02.036_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008251","article-title":"Human plague: An old scourge that needs new answers","volume":"14","author":"Vall\u00e8s","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ymthe.2026.02.036_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jobb.2020.02.001","article-title":"Deliberate release: Plague - A review","volume":"2","author":"Ansari","year":"2020","journal-title":"J. Biosaf. Biosecur."},{"key":"10.1016\/j.ymthe.2026.02.036_bib3","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/1749-4877.12511","article-title":"Plague reservoir species throughout the world","volume":"16","author":"Mahmoudi","year":"2021","journal-title":"Integr. Zool."},{"key":"10.1016\/j.ymthe.2026.02.036_bib4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3201\/eid2402.160122","article-title":"Ecologic Features of Plague Outbreak Areas, Democratic Republic of the Congo, 2004-2014","volume":"24","author":"Abedi","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ymthe.2026.02.036_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.15585\/mmwr.mm6909a5","article-title":"Intervention To Stop Transmission of Imported Pneumonic Plague - Uganda, 2019","volume":"69","author":"Apangu","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.ymthe.2026.02.036_bib6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/gcb.15966","article-title":"Plague risk in the western United States over seven decades of environmental change","volume":"28","author":"Carlson","year":"2022","journal-title":"Glob. Chang. Biol."},{"key":"10.1016\/j.ymthe.2026.02.036_bib7","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4269\/ajtmh.23-0331","article-title":"Plague Gives Surprises in the Second Decade of the Twenty-First Century","volume":"109","author":"Butler","year":"2023","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ymthe.2026.02.036_bib8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1473-3099(18)30730-8","article-title":"Epidemiological characteristics of an urban plague epidemic in Madagascar, August-November, 2017: an outbreak report","volume":"19","author":"Randremanana","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2026.02.036_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s41182-021-00349-5","article-title":"Epidemic of plague amidst COVID-19 in Madagascar: efforts, challenges, and recommendations","volume":"49","author":"Aborode","year":"2021","journal-title":"Trop. Med. Health"},{"key":"10.1016\/j.ymthe.2026.02.036_bib10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/cid\/ciab606","article-title":"Transmission of Antimicrobial Resistant Yersinia pestis During a Pneumonic Plague Outbreak","volume":"74","author":"Andrianaivoarimanana","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ymthe.2026.02.036_bib11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1586\/erv.13.42","article-title":"Live-attenuated Yersinia pestis vaccines","volume":"12","author":"Wang","year":"2013","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.ymthe.2026.02.036_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.micpath.2006.09.003","article-title":"Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates","volume":"42","author":"Williamson","year":"2007","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ymthe.2026.02.036_bib13","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1016\/j.vaccine.2009.01.050","article-title":"A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague","volume":"27","author":"Chichester","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2026.02.036_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12044","article-title":"Protecting against plague: towards a next-generation vaccine","volume":"172","author":"Williamson","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ymthe.2026.02.036_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1600-065X.2008.00674.x","article-title":"Immune defense against pneumonic plague","volume":"225","author":"Smiley","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ymthe.2026.02.036_bib16","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenoviruses as vaccine vectors","volume":"10","author":"Tatsis","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.02.036_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.coi.2016.05.014","article-title":"Viral vectors as vaccine platforms: from immunogenicity to impact","volume":"41","author":"Ewer","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ymthe.2026.02.036_bib18","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2016.4218","article-title":"Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial","volume":"315","author":"Milligan","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ymthe.2026.02.036_bib19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41591-020-01179-4","article-title":"Phase 1\/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses","volume":"27","author":"Barrett","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.02.036_bib20","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.02.036_bib21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jinf.2022.02.032","article-title":"Viral vectors expressing group B meningococcal outer membrane proteins induce strong antibody responses but fail to induce functional bactericidal activity","volume":"84","author":"Marsay","year":"2022","journal-title":"J. Infect."},{"key":"10.1016\/j.ymthe.2026.02.036_bib22","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3390\/vaccines2040772","article-title":"A Recombinant Raccoon Poxvirus Vaccine Expressing both Yersinia pestis F1 and Truncated V Antigens Protects Animals against Lethal Plague","volume":"2","author":"Rocke","year":"2014","journal-title":"Vaccines"},{"key":"10.1016\/j.ymthe.2026.02.036_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg1036","article-title":"A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium","volume":"9","author":"Kon","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2026.02.036_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1247041","article-title":"A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague","volume":"14","author":"Shattock","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ymthe.2026.02.036_bib25","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1086\/507644","article-title":"Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen","volume":"194","author":"Chiuchiolo","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2026.02.036_bib26","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/CVI.00150-16","article-title":"A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates","volume":"23","author":"Sha","year":"2016","journal-title":"Clin. Vaccin. Immunol."},{"key":"10.1016\/j.ymthe.2026.02.036_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade3901","article-title":"An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease","volume":"15","author":"Dold","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.02.036_bib28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13578-022-00809-3","article-title":"Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus","volume":"12","author":"Sheerin","year":"2022","journal-title":"Cell Biosci."},{"key":"10.1016\/j.ymthe.2026.02.036_bib29","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1038\/s41467-021-24906-y","article-title":"A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial","volume":"12","author":"Folegatti","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.02.036_bib30","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1016\/j.vaccine.2017.10.078","article-title":"Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection","volume":"35","author":"Gomi","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2026.02.036_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3865802","article-title":"Chlamydial Type III Secretion System Needle Protein Induces Protective Immunity against Chlamydia muridarum Intravaginal Infection","volume":"2017","author":"Koroleva","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ymthe.2026.02.036_bib32","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","volume":"173","author":"Wang","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.02.036_bib33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41541-021-00369-6","article-title":"Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action","volume":"6","author":"Heinz","year":"2021","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2026.02.036_bib34","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1473-3099(20)30019-0","article-title":"Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial","volume":"20","author":"Tapia","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2026.02.036_bib35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.ymthe.2026.02.036_bib36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","article-title":"A new improved sub-unit vaccine for plague: the basis of protection","volume":"12","author":"Williamson","year":"1995","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.ymthe.2026.02.036_bib37","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.vaccine.2009.10.043","article-title":"Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis)","volume":"28","author":"Rocke","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2026.02.036_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/vbz.2009.0050","article-title":"Consumption of baits containing raccoon pox-based plague vaccines protects black-tailed prairie dogs (Cynomys ludovicianus)","volume":"10","author":"Rocke","year":"2010","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.ymthe.2026.02.036_bib39","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1016\/S0264-410X(03)00379-7","article-title":"Protective efficacy of a fully recombinant plague vaccine in the guinea pig","volume":"21","author":"Jones","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2026.02.036_bib40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1574-695X.1998.tb01168.x","article-title":"Macromolecular organisation of recombinant Yersinia pestis F1 antigen and the effect of structure on immunogenicity","volume":"21","author":"Miller","year":"1998","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.ymthe.2026.02.036_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/CVI.00333-08","article-title":"Flagellin-F1-V Fusion Protein Is an Effective Plague Vaccine in Mice and Two Species of Nonhuman Primates","volume":"16","author":"Mizel","year":"2009","journal-title":"Clin. Vaccin. Immunol."},{"key":"10.1016\/j.ymthe.2026.02.036_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/365980","article-title":"The role of immune correlates and surrogate markers in the development of vaccines and immunotherapies for plague","volume":"2012","author":"Williamson","year":"2012","journal-title":"Adv. Prev. Med."},{"key":"10.1016\/j.ymthe.2026.02.036_bib43","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1128\/IAI.71.4.2234-2238.2003","article-title":"Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis","volume":"71","author":"Hill","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2026.02.036_bib44","doi-asserted-by":"crossref","first-page":"807564","DOI":"10.1155\/2014\/807564","article-title":"Efficacy of Primate Humoral Passive Transfer in a Murine Model of Pneumonic Plague Is Mouse Strain-Dependent","volume":"2014","author":"Graham","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.ymthe.2026.02.036_bib45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.micpath.2004.06.009","article-title":"Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague","volume":"37","author":"Elvin","year":"2004","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ymthe.2026.02.036_bib46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4049\/jimmunol.2200487","article-title":"Lung Resident Memory T Cells Activated by Oral Vaccination Afford Comprehensive Protection against Pneumonic Yersinia pestis Infection","volume":"210","author":"Singh","year":"2023","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.02.036_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1017385","article-title":"The magnitude of the germinal center B cell and T follicular helper cell response predicts long-lasting antibody titers to plague vaccination","volume":"13","author":"Galloway","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.02.036_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003548","article-title":"Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice","volume":"3","author":"Croyle","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.02.036_bib49","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1016\/j.vaccine.2023.04.020","article-title":"Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models","volume":"41","author":"Freitag","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2026.02.036_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109400","article-title":"A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters","volume":"36","author":"Bricker","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2026.02.036_bib51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41541-023-00623-z","article-title":"Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice","volume":"8","author":"Afkhami","year":"2023","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2026.02.036_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104298","article-title":"Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial","volume":"85","author":"Madhavan","year":"2022","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ymthe.2026.02.036_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac5745","article-title":"Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults","volume":"7","author":"Green","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.02.036_bib54","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/iai.64.11.4580-4585.1996","article-title":"Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis","volume":"64","author":"Anderson","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2026.02.036_bib55","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2026.02.036_bib56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41541-020-00275-3","article-title":"A new generation needle- and adjuvant-free trivalent plague vaccine utilizing adenovirus-5 nanoparticle platform","volume":"6","author":"Kilgore","year":"2021","journal-title":"Npj Vaccin."},{"key":"10.1016\/j.ymthe.2026.02.036_bib57","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1038\/s41598-020-61730-8","article-title":"Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling molecule","volume":"10","author":"Rollier","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162600122X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162600122X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:15:20Z","timestamp":1788178520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162600122X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S152500162600122X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.02.036","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An adenoviral-vectored vaccine protects mice against aerosol challenge with Yersinia pestis","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.02.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}